Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We report our experience using a biodegradable calcium sulphate antibiotic carrier containing tobramycin in the surgical management of patients with chronic osteomyelitis. The patients were reviewed to determine the rate of recurrent infection, the filling of bony defects, and any problems with wound healing. A total of 193 patients (195 cases) with a mean age of 46.1 years (16.1 to 82.0) underwent surgery. According to the Cierny-Mader classification of osteomyelitis there were 12 type I, 1 type II, 144 type III and 38 type IV cases. The mean follow-up was 3.7 years (1.3 to 7.1) with recurrent infection occurring in 18 cases (9.2%) at a mean of 10.3 months post-operatively (1 to 25.0). After further treatment the infection resolved in 191 cases (97.9%). Prolonged wound ooze (longer than two weeks post-operatively) occurred in 30 cases (15.4%) in which there were no recurrent infection. Radiographic assessment at final follow-up showed no filling of the defect with bone in 67 (36.6%), partial filling in 108 (59.0%) and complete filling in eight (4.4%). A fracture occurred in nine (4.6%) of the treated osteomyelitic segments at a mean of 1.9 years (0.4 to 4.9) after operation. We conclude that Osteoset T is helpful in the management of patients with chronic osteomyelitis, but the filling of the defect in bone is variable. Prolonged wound ooze is usually self-limiting and not associated with recurrent infection.

Original publication

DOI

10.1302/0301-620x.96b6.32756

Type

Journal article

Journal

The bone & joint journal

Publication Date

06/2014

Volume

96-B

Pages

829 - 836

Addresses

Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Trust, Windmill Road, Headington, Oxford, OX3 7LD, UK.

Keywords

Humans, Osteomyelitis, Chronic Disease, Calcium Sulfate, Tobramycin, Drug Carriers, Treatment Outcome, Antibiotic Prophylaxis, Intraoperative Care, Debridement, Severity of Illness Index, Statistics, Nonparametric, Cohort Studies, Follow-Up Studies, Prospective Studies, Absorbable Implants, Wound Healing, Adolescent, Adult, Aged, Aged, 80 and over, Middle Aged, Female, Male, Kaplan-Meier Estimate